Proximal Ventures Closes $27.5M Debut Fund for AI Life Sciences
Proximal Ventures closed a $27.5M debut fund on November 10, 2026 to back pre-seed and seed AI-native infrastructure across the life-sciences value chain, from clinical trials to manufacturing.